Dimerization of human pS2 (TFF1) plays a key role in its protective/healing effects

Journal of Pathology

Volumn 185, Issue 2, 1998, Pages 153-158

  Marchbank, Tania ^a   Westley, Bruce R ^b   May, Felicity E B ^b   Calnan, Denis P ^a   Playford, Raymond J ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cell culture; Cytoprotection; Gastric ulcer; Healing; PS2 TFF1; Trefoil peptides

Indexed keywords

TREFOIL PEPTIDE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DIMERIZATION; EPITHELIZATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH INJURY; STOMACH ULCER; WOUND HEALING;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL DIVISION; CELL MOVEMENT; DIMERIZATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC MUCOSA; HT29 CELLS; HUMANS; INDOMETHACIN; MALE; PROTEINS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; TUMOR SUPPRESSOR PROTEINS; WOUND HEALING;

EID: 0031813248     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199806)185:2<153::AID-PATH87>3.0.CO;2-5     Document Type: Article

References (32)

1. Critchlow J, Magee D, Ho K, Takeuchi K, Silen W. Requirements For restitution of the surface epithelium of frog stomach after mucosal injury. Gastroenterology 1985; 88: 237-249.
2. Silen W. Gastric mucosal defence and repair. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. 2nd edn. New York: Raven Press, 1987; 1044-1069.
3. Wright NA, Hoffman W, Otto WR, Thim L. Rolling in the clover: trefoil factor family (TFF)-domain peptides, cell migration and cancer. FEBS Lett 1997; 408: 121-123.
4. Wright NA, Poulsom R, Stamp G, et al. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993; 104: 12-20.
5. Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, Wright NA. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor, and transforming growth factor alpha mRNAs in rat stomach. J Pathol 1995; 175: 405-414.
6. Playford RJ, Marchbank T, Chinery R, et al. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995; 108: 108-116.
7. Chinery R, Playford RJ. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin Sci 1995; 88: 401-403.
8. Mashimo H, Wu C, Podolsky DK, Fishman MC. Impaired defence of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996; 274: 262-265.
9. Lefebvre O, Chenard M-P, Masson R, et al. Gastric mucosa abnormalities and tumourigenesis in mice lacking the pS2 trefoil protein. Science 1996; 274: 259-262.
10. Playford RJ, Marchbank T, Goodlad RA, et al. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci USA 1996; 93: 2137-2142.
11. Babyatsky MW, DeBeaumont M, Thim L, Podolsky DK. Oral trefoil peptides protect against ethanol and indomethacin induced gastric injury in rats. Gastroenterology 1996; 110: 489-497.
12. Playford RJ, Hanby AM, Gschmeissner S, Peiffer LP, Wright NA, McGarrity T. The epidermal growth factor receptor (EGF-R) is present on the basolateral, but not the apical, surface of enterocytes in the human gastrointestinal tract. Gut 1996; 39: 262-266.
13. Tanaka S, Podolsky DK, Engel E, Guth PH, Kaunitz JD. Gastroprotective effects of human spasmolytic polypeptide (hSP) decrease permeation through gastric mucus in vivo and in vitro. Am J Physiol 1997; 35: G1473-G1480.
14. Polshakov VI, Williams MA, Gargaro AR, et al. High-resolution solution structure of human pNR-2/pS2: a single trefoil motif protein. J Mol Biol 1997; 267: 418-432.
15. Chinery R, Bates PA, De A, Freemont PS. Characterisation of the single copy trefoil peptides intestinal trefoil factor and pS2 and their ability to form covalent dimers. FEBS Lett 1995; 357: 50-54.
16. Thim L, Woldike HF, Nielsen PF, et al. Characterisation of human and rat intestinal trefoil factor produced in yeast. Biochemistry 1995; 34: 4757-4764.
17. Chadwick MP, Westley BR, May FEB. Homodimerisation and hetero-oligomerisation of the single-domain trefoil protein pNR-2/pS2 through cysteine 58. Biochem J 1997; 327: 117-123.
18. 58. Biochem J 1995; 308: 1001-1007.
19. Playford RJ, Vesey DA, Haldane S, Alison M, Calam J. Dose-dependent effects of fentanyl on indomethacin-induced gastric damage. Digestion 1991; 49: 198-203.
20. 1 like molecules by plasmin during co-culture. J Cell Biol 1989; 109: 309-315.
21. Williams R, Elia G, Stamp WL, Oates T, Wright NA, Lalani EN. Characterisation of monoclonal antibodies raised to c-terminal peptides of pS2-a major trefoil peptide and motility factor expressed in adenocarcinomas and regions of mucosal injury. Hum Pathol 1996; 27: 1259-1266.
22. Rees WDW, Turnberg LA. Mechanism of gastric mucosal protection: a role for the mucus bicarbonate barrier. Clin Sci 1982; 62: 343-348.
23. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky DK. Trefoil peptides promote epithelial migration through a transforming growth factor-independent pathway. J Clin Invest 1994; 94: 376-383.
24. Dignass A, Podolsky DK. Cytokine modulation of intestinal epithelial restitution: central role of transforming growth factor β. Gastroenterology 1993; 105: 1323-1332.
25. Poulsom R, Hanby AM, Lalani E-N, Hauser F, Hoffman W, Stamp GWH. Intestinal trefoil factor (TFF3) and pS2 (TFF1), but not spasmolytic polypeptide (TFF2) mRNAs, are co-expressed in normal hyperplastic, and neoplastic human breast epithelium. J Pathol 1997; 183: 30-38.
26. Williams R, Stamp GWH, Gilbert C, Pignatelli M, Lalani E-N. pS2 transfection of murine adenocarcinoma cell line (410.4) enhances dispersed growth pattern in 3-D collagen gel. J Cell Sci 1996; 109: 63-71.
27. Levi S, Shaw-Smith C. Non-sieroidal anti-inflammatory drugs: how do they damage the gut? Br J Rheum 1994; 33: 605-612.
28. McKenzie C, Marchbank T, Playford RJ, Otto W, Thim L, Parsons ME. Pancreatic spasmolytic polypeptide (PSP) protects the gastric mucosa but does not inhibit acid secretion or motility. Am J Physiol 1997; 36: G112-G117.
29. Chinery R, Cox HM. Immunoprecipitation and characterization of a binding protein specific for the peptide intestinal trefoil factor. Peptides 1995; 16: 749-755.
30. Rasmusin TN, Thim L, Raaberg L, Harling H, Holst JJ. Pancreatic spasmolytic polypeptide, a potential growth factor for the intestine: localization and control of secretion. Digestion 1990; 46: A90.
31. Carr MD, Bauer CJ, Gradwell MJ, Feeney J. Solution structure of a trefoil motif containing cell growth factor, porcine spasmolytic protein. Proc Natl Acad Sci USA 1995; 91: 2206-2210.
32. Cunningham BC, Ultsch M, de Vos AM, Mulkerrin MG, Clauser KR, Wells JA. Dimerization of the extracelluar domain of the growth hormone receptor by a single hormone molecule. Science 1991; 254: 821-825.